Stem Cell Secretome for Aging Therapy: Potential Benefits and Key Challenges

The global aging population is expanding rapidly, making aging a major driver of mortality and morbidity. Stem cell therapy has emerged as a promising strategy for mitigating aging and treating aging-related diseases. Its therapeutic benefits are increasingly attributed to the stem cell secretome, a complex mixture of paracrine factors and extracellular vesicles that underlies tissue repair and homeostasis. This review consolidates recent preclinical and clinical advances in stem cell secretome research, analyzing its composition, biological functions, and therapeutic applications in the context of aging and associated pathologies. The stem cell secretome demonstrates significant potential as a transformative anti-aging intervention. It orchestrates key regenerative processes, including angiogenesis, immunomodulation, and cell survival, thereby mitigating cellular senescence and aging-related tissue degeneration. Furthermore, its versatility allows it to be engineered as a customizable drug delivery platform. Nonetheless, clinical translation faces several challenges, including the elucidation of underlying mechanisms, identification of active components, optimization of dosing strategies, and standardization of cell sources. The stem cell secretome emerges as a highly promising, cell-free alternative to whole-cell therapies. To fully unlock its clinical potential, future research must prioritize addressing existing challenges, particularly in standardizing production, defining potency, and ensuring safety and efficacy in human applications.